the a priori hypothesis that diltiazem would reduce the frequency and repetitiveness of ventricular arrhythmias was tested 3 months after myocardial infarction in patients participating in the multicenter diltiazem postinfarction trial .
C0027051
myocardial
C0012373
diltiazem